Investing, US News

Gilead CEO: Oral Version Of Covid Drug Remdesivir In Early Testing

Gilead Sciences Daniel O'Day

Following are excerpts from CNBC interviews with Gilead Sciences, Inc. (NASDAQ:GILD) Chairman & CEO Daniel O’Day and Novavax, Inc. (NASDAQ:NVAX) President & CEO Stanley Erck on CNBC’s “Squawk on the Street” (M-F 9AM – 11AM ET) today, Monday, January 10th. Following is a link to video on CNBC.com: Q4 2021 hedge fund letters, conferences and […]

Jump To The Original Source

Facebook Comments

Check Also

Wife Stands Off With Hospital To Keep Her Husband Alive, And Wins

Wife Stands Off With Hospital To Keep Her ...

Archives